Harrow (HROW) Shares Outstanding (2010 - 2026)
Harrow (HROW) posted quarterly Shares Outstanding (Entity) of $37.3 million for Q1 2026, up 4.53% year-over-year from $35.7 million in Q1 2025, and little changed quarter-over-quarter from $37.2 million in Q4 2025.
Harrow (HROW) Shares Outstanding (2010 - 2026) Analysis & Trends
Harrow's Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $37.3 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 4.53% year-over-year to $37.3 million; the TTM figure through Mar 2026 stood at $37.3 million (up 4.53% YoY), while the FY2025 annual figure was $37.2 million, up 4.51% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $37.3 million, roughly flat from $37.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $37.3 million in Q1 2026, with the low at $27.0 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $35.4 million (2024), against an average of $33.4 million.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) rose 0.64% in 2022, then rose 29.71% in 2023.
- Harrow's Shares Outstanding (Entity) stood at $29.9 million in 2022, then climbed by 17.61% to $35.2 million in 2023, then gained by 1.29% to $35.6 million in 2024, then climbed by 4.51% to $37.2 million in 2025, then advanced by 0.11% to $37.3 million in 2026.
- Business Quant data shows HROW's Shares Outstanding (Entity) at $37.3 million in Q1 2026, $37.2 million in Q4 2025, and $37.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 832.44 Mn |
| 10 | Harrow | 1.55 Bn | 1.47 Bn | 50.36 Mn | 37.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.35 Mn |
| Mar 31, 2026 | 37.23 Mn |
| Dec 31, 2025 | 36.76 Mn |
| Sep 30, 2025 | 37.15 Mn |
| Jun 30, 2025 | 36.79 Mn |
| Mar 31, 2025 | 35.83 Mn |
| Dec 31, 2024 | 35.65 Mn |
| Sep 30, 2024 | 35.70 Mn |
| Jun 30, 2024 | 35.62 Mn |
| Mar 31, 2024 | 35.47 Mn |
| Dec 31, 2023 | 32.62 Mn |
| Sep 30, 2023 | 34.26 Mn |
| Jun 30, 2023 | 30.46 Mn |
| Mar 31, 2023 | 30.29 Mn |
| Dec 31, 2022 | 27.46 Mn |
| Sep 30, 2022 | 27.35 Mn |
| Jun 30, 2022 | 27.30 Mn |
| Mar 31, 2022 | 27.23 Mn |
| Dec 31, 2021 | 26.76 Mn |
| Sep 30, 2021 | 27.11 Mn |